Public Health Stakeholder Call Tomorrow 12PM EST, Dec 14: Public Release of the Institute of Med.
Tuesday, December 13, 2011
Posted by: Natalia Gromov
Family Smoking Prevention and Tobacco Control Act requires the FDA to consult
with the Institute of Medicine (IOM) on the design and conduct of studies and
surveillance required for the assessment and ongoing review of modified risk
tobacco products. Tomorrow, the IOM will release a report on the design and
conduct of studies which the FDA will use in the assessment and ongoing review
of modified risk tobacco products. Please see below for an invitation from the
The Institute of Medicine report, "Scientific Standards for
Studies on Modified Risk Tobacco Products,” will be publicly released at 11:00
AM EST on December 14th, 2011.
This report provides advice to the FDA on the
minimum standards for scientific studies to allow the marketing of modified risk
tobacco products, and for post-market studies of marketed products, as described
in section 911 of the Family Smoking Prevention and Tobacco Control Act of 2009.
More information on the report can
be found at: www.iom.edu/modifiedrisktobacco
The IOM will be hosting a teleconference briefing about the report for
interested parties. During the briefing, the chair of the committee and several
committee members will briefly review the main recommendations and findings of
the report, and will also be available to answer questions.
teleconference will be from 12:00 PM EST to 12:45 PM EST.
Phone Number: 866-528-2256
Source: Center for Tobacco Products/FDA